Cognition Therapeutics, Inc. (NASDAQ:CGTX) Given Consensus Recommendation of “Buy” by Brokerages
Cognition Therapeutics, Inc. (NASDAQ:CGTX – Get Free Report) has received an average rating of “Buy” from the six brokerages that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold recommendation, four have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. […]
Cognition Therapeutics, Inc. (NASDAQ:CGTX – Get Free Report) has received an average rating of “Buy” from the six brokerages that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold recommendation, four have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. […]
